319 related articles for article (PubMed ID: 23154546)
1. A pilot characterization of human lung NSCLC by protein pathway activation mapping.
Zupa A; Improta G; Silvestri A; Pin E; Deng J; Aieta M; Musto P; Nitti D; Mammano E; Liotta L; Belluco C; Wulfkuhle J; Petricoin E
J Thorac Oncol; 2012 Dec; 7(12):1755-1766. PubMed ID: 23154546
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of phosphorylated mTOR/RPS6KB1 in non- small cell lung cancer.
Zhang Y; Ni HJ; Cheng DY
Asian Pac J Cancer Prev; 2013; 14(6):3725-8. PubMed ID: 23886172
[TBL] [Abstract][Full Text] [Related]
3. Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation.
Improta G; Zupa A; Fillmore H; Deng J; Aieta M; Musto P; Liotta LA; Broaddus W; Petricoin EF; Wulfkuhle JD
J Proteome Res; 2011 Jul; 10(7):3089-97. PubMed ID: 21574647
[TBL] [Abstract][Full Text] [Related]
4. Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type.
VanMeter AJ; Rodriguez AS; Bowman ED; Jen J; Harris CC; Deng J; Calvert VS; Silvestri A; Fredolini C; Chandhoke V; Petricoin EF; Liotta LA; Espina V
Mol Cell Proteomics; 2008 Oct; 7(10):1902-24. PubMed ID: 18687633
[TBL] [Abstract][Full Text] [Related]
5. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
[TBL] [Abstract][Full Text] [Related]
6. Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma.
Stojsic J; Stankovic T; Stojkovic S; Milinkovic V; Dinic J; Milosevic Z; Milovanovic Z; Tanic N; Bankovic J
Exp Mol Pathol; 2015 Feb; 98(1):27-32. PubMed ID: 25449334
[TBL] [Abstract][Full Text] [Related]
7. PAQR3 suppresses the growth of non-small cell lung cancer cells via modulation of EGFR-mediated autophagy.
Cao Q; You X; Xu L; Wang L; Chen Y
Autophagy; 2020 Jul; 16(7):1236-1247. PubMed ID: 31448672
[TBL] [Abstract][Full Text] [Related]
8. RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer.
Guo C; Hao C; Shao R; Fang B; Correa AM; Hofstetter WL; Roth JA; Behrens C; Kalhor N; Wistuba II; Swisher SG; Pataer A
Oncotarget; 2015 May; 6(13):11114-24. PubMed ID: 25798539
[TBL] [Abstract][Full Text] [Related]
9. Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC).
Mukohara T; Kudoh S; Yamauchi S; Kimura T; Yoshimura N; Kanazawa H; Hirata K; Wanibuchi H; Fukushima S; Inoue K; Yoshikawa J
Lung Cancer; 2003 Aug; 41(2):123-30. PubMed ID: 12871775
[TBL] [Abstract][Full Text] [Related]
10. The effects of sonic hedgehog signaling pathway components on non-small-cell lung cancer progression and clinical outcome.
Hwang J; Kang MH; Yoo YA; Quan YH; Kim HK; Oh SC; Choi YH
World J Surg Oncol; 2014 Aug; 12():268. PubMed ID: 25141859
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta specifically enhances the metastatic attributes of murine lung adenocarcinoma: implications for human non-small cell lung cancer.
Vázquez PF; Carlini MJ; Daroqui MC; Colombo L; Dalurzo ML; Smith DE; Grasselli J; Pallotta MG; Ehrlich M; Bal de Kier Joffé ED; Puricelli L
Clin Exp Metastasis; 2013 Dec; 30(8):993-1007. PubMed ID: 23832740
[TBL] [Abstract][Full Text] [Related]
12. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W
PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362
[TBL] [Abstract][Full Text] [Related]
13. Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer.
Zhang T; Yu TT; Zhang DM; Hou XM; Liu XJ; Zhao D; Shan L
Med Oncol; 2014 May; 31(5):963. PubMed ID: 24748406
[TBL] [Abstract][Full Text] [Related]
14. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.
Onn A; Correa AM; Gilcrease M; Isobe T; Massarelli E; Bucana CD; O'Reilly MS; Hong WK; Fidler IJ; Putnam JB; Herbst RS
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):136-43. PubMed ID: 14734462
[TBL] [Abstract][Full Text] [Related]
15. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
Haura EB; Zheng Z; Song L; Cantor A; Bepler G
Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the mammalian target of rapamycin: a novel biomarker for poor survival in resected early stage non-small cell lung cancer.
Dhillon T; Mauri FA; Bellezza G; Cagini L; Barbareschi M; North BV; Seckl MJ
J Thorac Oncol; 2010 Mar; 5(3):314-9. PubMed ID: 20093977
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
[TBL] [Abstract][Full Text] [Related]
18. Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy.
Thomson S; Petti F; Sujka-Kwok I; Epstein D; Haley JD
Clin Exp Metastasis; 2008; 25(8):843-54. PubMed ID: 18696232
[TBL] [Abstract][Full Text] [Related]
19. CD147-CD98hc complex contributes to poor prognosis of non-small cell lung cancer patients through promoting cell proliferation via the PI3K/Akt signaling pathway.
Fei F; Li X; Xu L; Li D; Zhang Z; Guo X; Yang H; Chen Z; Xing J
Ann Surg Oncol; 2014 Dec; 21(13):4359-68. PubMed ID: 25084765
[TBL] [Abstract][Full Text] [Related]
20. High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.
Nunez MI; Behrens C; Woods DM; Lin H; Suraokar M; Kadara H; Hofstetter W; Kalhor N; Lee JJ; Franklin W; Stewart DJ; Wistuba II
J Thorac Oncol; 2012 May; 7(5):833-40. PubMed ID: 22729036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
